Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Piracetam Interactions with Neuroleptics in Psychopharmacological Tests

View through CrossRef
Two psychopharmacological tests which usually predict neuroleptic activity were conducted after joint administration of piracetam and three neuroleptics (haloperidol, fluphenazine and sulpiride) chosen for their different chemical classes and dopaminergic affinities. In these tests, specific doses of the neuroleptics were used to determine whether piracetam induced potentiation or antagonism of their action. Overall, piracetam increased neuroleptic action regardless of the administration timetable used, but the interaction of fluphenazine differed from that of the other two substances, because piracetam did not modify its action in a specific test of the presynaptic DA-2 dopaminergic receptors. This variation for fluphenazine may be explained by the fact that its pK<sub>a</sub> value is closer to that of piracetam, thus preventing better bioavailability of the neuroleptic, or its better affinity for DA-1 dopaminergic receptors. Nevertheless, the variation may have been due to a differing affinity for dopaminergic receptors, although this hypothesis is not completely satisfactory because it does not account for differences due to the administration timetable. It is thus suggested that action occurs on nonspecific sites and has the effect of increasing overall neuroleptic bioavailability.
Title: Piracetam Interactions with Neuroleptics in Psychopharmacological Tests
Description:
Two psychopharmacological tests which usually predict neuroleptic activity were conducted after joint administration of piracetam and three neuroleptics (haloperidol, fluphenazine and sulpiride) chosen for their different chemical classes and dopaminergic affinities.
In these tests, specific doses of the neuroleptics were used to determine whether piracetam induced potentiation or antagonism of their action.
Overall, piracetam increased neuroleptic action regardless of the administration timetable used, but the interaction of fluphenazine differed from that of the other two substances, because piracetam did not modify its action in a specific test of the presynaptic DA-2 dopaminergic receptors.
This variation for fluphenazine may be explained by the fact that its pK<sub>a</sub> value is closer to that of piracetam, thus preventing better bioavailability of the neuroleptic, or its better affinity for DA-1 dopaminergic receptors.
Nevertheless, the variation may have been due to a differing affinity for dopaminergic receptors, although this hypothesis is not completely satisfactory because it does not account for differences due to the administration timetable.
It is thus suggested that action occurs on nonspecific sites and has the effect of increasing overall neuroleptic bioavailability.

Related Results

A Pilot Study of Piracetam in Cuprophan Hemodialysis
A Pilot Study of Piracetam in Cuprophan Hemodialysis
Abstract: Twelve patients, 8 male and 4 female, aged from 26 to 70 years were studied. They were on hemodialysis (HD) 4 h three times weekly with cuprophan hollow fiber dialyzers ...
Assessment of the Effective Piracetam Oral Iron for Children with Breath Holding Spell in Tertiary Care Hospitals
Assessment of the Effective Piracetam Oral Iron for Children with Breath Holding Spell in Tertiary Care Hospitals
BHS (breath holding spell) are very successive & significant demonstrative difficulties in pediatric medicine. The obviously terrifying functions are generally basic in youngst...
Unique Severe HyperEkplexia-Like Apneic Events (SHELAE) Improved by High-Dose Piracetam
Unique Severe HyperEkplexia-Like Apneic Events (SHELAE) Improved by High-Dose Piracetam
Breath-holding spells are common non-epileptic events with onset between 6 months and 18 months of age that are usually triggered by minor painful events or strong emotions. Sympto...
Review of psychopharmacology
Review of psychopharmacology
In India, one of the primary causes of non-fatal disease burden is psychopharmacological diseases. The prevalence of psychopharmacological disorders in India was one in seven. Desp...
A Short Review on Animal Models in Psychopharmacology
A Short Review on Animal Models in Psychopharmacology
Psychopharmacological disorders are among the leading cause of non-fatal disease burden in India. One in seven Indians was affected by psychopharmacological disorders. Although psy...
Quantitative EEG and Neuropsychological Effects of Piracetam and of the Association Piracetam-Lecithin in Healthy Volunteers
Quantitative EEG and Neuropsychological Effects of Piracetam and of the Association Piracetam-Lecithin in Healthy Volunteers
The electroencephalographic (EEG) and neuropsychological effects of single, oral doses or piracetam (800–6,400 mg) and of its association with lecithin (4,800 mg and 25 g, respecti...
Effect of Piracetam in Huntington’s Chorea
Effect of Piracetam in Huntington’s Chorea
Piracetam has been described to improve neuroleptic-induced acute extrapyramidal syndrome where a central dopaminergic hyperactivity is implicated. In Huntington’s chorea, this abn...

Back to Top